These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 25829424)
41. HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Du W; Zhang L; Brett-Morris A; Aguila B; Kerner J; Hoppel CL; Puchowicz M; Serra D; Herrero L; Rini BI; Campbell S; Welford SM Nat Commun; 2017 Nov; 8(1):1769. PubMed ID: 29176561 [TBL] [Abstract][Full Text] [Related]
42. Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma. Riscal R; Gardner SM; Coffey NJ; Carens M; Mesaros C; Xu JP; Xue Y; Davis L; Demczyszyn S; Vogt A; Olia A; Finan JM; Godfrey J; Schultz DC; Blair IA; Keith B; Marmorstein R; Skuli N; Simon MC Cancer Res; 2024 May; 84(10):1570-1582. PubMed ID: 38417134 [TBL] [Abstract][Full Text] [Related]
43. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Liu MY; Poellinger L; Walker CL Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296 [TBL] [Abstract][Full Text] [Related]
44. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447 [TBL] [Abstract][Full Text] [Related]
45. Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. Wrzesiński T; Szelag M; Cieślikowski WA; Ida A; Giles R; Zodro E; Szumska J; Poźniak J; Kwias Z; Bluyssen HA; Wesoly J BMC Cancer; 2015 Jul; 15():518. PubMed ID: 26169495 [TBL] [Abstract][Full Text] [Related]
46. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene]. Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350 [TBL] [Abstract][Full Text] [Related]
47. HIF2α-induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma. Quan Y; Dai J; Zhou S; Zhao L; Jin L; Long Y; Liu S; Hu Y; Liu Y; Zhao J; Ding Z FEBS Open Bio; 2023 Apr; 13(4):638-654. PubMed ID: 36728187 [TBL] [Abstract][Full Text] [Related]
48. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974 [TBL] [Abstract][Full Text] [Related]
49. A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma. Wallace EM; Rizzi JP; Han G; Wehn PM; Cao Z; Du X; Cheng T; Czerwinski RM; Dixon DD; Goggin BS; Grina JA; Halfmann MM; Maddie MA; Olive SR; Schlachter ST; Tan H; Wang B; Wang K; Xie S; Xu R; Yang H; Josey JA Cancer Res; 2016 Sep; 76(18):5491-500. PubMed ID: 27635045 [TBL] [Abstract][Full Text] [Related]
50. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
51. PLIN2 is a Key Regulator of the Unfolded Protein Response and Endoplasmic Reticulum Stress Resolution in Pancreatic β Cells. Chen E; Tsai TH; Li L; Saha P; Chan L; Chang BH Sci Rep; 2017 Jan; 7():40855. PubMed ID: 28102311 [TBL] [Abstract][Full Text] [Related]
52. MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1β in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis. Lee CH; Hung PF; Lu SC; Chung HL; Chiang SL; Wu CT; Chou WC; Sun CY Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816951 [TBL] [Abstract][Full Text] [Related]
53. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832 [TBL] [Abstract][Full Text] [Related]
54. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related]
55. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy. Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060 [TBL] [Abstract][Full Text] [Related]
56. MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression. Wang S; Wang K; Yue D; Yang X; Pan X; Kong F; Zhao R; Bie Q; Tian D; Zhu S; He B; Bin Z Br J Cancer; 2024 Sep; 131(4):641-654. PubMed ID: 38906969 [TBL] [Abstract][Full Text] [Related]
57. Positive feedback loop and synergistic effects between hypoxia-inducible factor-2α and stearoyl-CoA desaturase-1 promote tumorigenesis in clear cell renal cell carcinoma. Zhang Y; Wang H; Zhang J; Lv J; Huang Y Cancer Sci; 2013 Apr; 104(4):416-22. PubMed ID: 23331615 [TBL] [Abstract][Full Text] [Related]
58. 36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells. Bombelli S; Torsello B; De Marco S; Lucarelli G; Cifola I; Grasselli C; Strada G; Bovo G; Perego RA; Bianchi C Am J Pathol; 2020 Nov; 190(11):2317-2326. PubMed ID: 32861643 [TBL] [Abstract][Full Text] [Related]
59. ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy. Messai Y; Noman MZ; Hasmim M; Janji B; Tittarelli A; Boutet M; Baud V; Viry E; Billot K; Nanbakhsh A; Ben Safta T; Richon C; Ferlicot S; Donnadieu E; Couve S; Gardie B; Orlanducci F; Albiges L; Thiery J; Olive D; Escudier B; Chouaib S Cancer Res; 2014 Dec; 74(23):6820-32. PubMed ID: 25297632 [TBL] [Abstract][Full Text] [Related]
60. Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma. Liu W; Chen H; Wong N; Haynes W; Baker CM; Wang X Cancer Lett; 2017 May; 394():65-75. PubMed ID: 28257806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]